Chromosomally encoded cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A. 1994

J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
Muséum National Histoire Naturelle, CNRS URA 401, Paris, France.

Proteus vulgaris RO104 strain produces a chromosomally encoded beta-lactamase that confers resistance to various beta-lactam antibiotics including methoxyimino third-generation cephalosporins. The beta-lactamase hydrolyzes first- and second-generation cephalosporins efficiently and cefotaxime to a lesser extent. Catalytic activity is inhibited by low concentrations of clavulanic acid and sulbactam. By its broad-spectrum substrate profile, beta-lactamase of Proteus vulgaris RO104 belongs to the group 2e defined by Bush. The protein purified to homogeneity by a four-step procedure was characterized by a pI of 8.31 and a specific activity of 1200 U/mg. The beta-lactamase was digested by trypsin, endoproteinase Asp-N and chymotrypsin. Amino-acid sequence determinations of the resulting peptides allowed the alignment of the 271 amino-acid residues of the protein which did not contain any cysteine residue. From amino-acid sequence comparisons, Proteus vulgaris RO104 beta-lactamase was found to share about 68% identity with the chromosomally mediated beta-lactamases of Klebsiella oxytoca D488 and E23004. Therefore, the cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011514 Proteus vulgaris A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis.
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D016415 Sequence Alignment The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms. Sequence Homology Determination,Determination, Sequence Homology,Alignment, Sequence,Alignments, Sequence,Determinations, Sequence Homology,Sequence Alignments,Sequence Homology Determinations

Related Publications

J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
May 1998, Antimicrobial agents and chemotherapy,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
December 2001, Antimicrobial agents and chemotherapy,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
November 1975, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
November 2005, Antimicrobial agents and chemotherapy,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
June 2002, Antimicrobial agents and chemotherapy,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
March 2002, Journal of molecular biology,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
January 1986, Journal of general microbiology,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
October 2001, Antimicrobial agents and chemotherapy,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
November 1994, European journal of biochemistry,
J Péduzzi, and A Reynaud, and P Baron, and M Barthélémy, and R Labia
January 2004, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!